Jun 4, 2026 · 23 min · 9 segments
We love to hear from our listeners. Send us a message. In episode 130 of Cell & Gene: The Podcast, Dr. Naji Gehchan, Chief Medical and Development…
Naji GehchanGuestErin HarrisHost
Uh, so as a company, we've been focused since the beginning to bring, uh, the potential of cell therapy, and specifically CAR Ts, uh, to patients who are suffering from autoimmune diseases.
So our first indications we're developing is stiff person syndrome, and I'm sure we're gonna talk about this, but also other debilitating diseases like myasthenia gravis and other, uh, neuroimmunological diseases that we're pursuing earlier in our pipeline.
So really the focus of, um, of our team has been to advance, uh, this, uh, this therapy, uh, that is still investigational, but really develop it and bring it to patients because it can have this promise of freeing patients from the burden of their autoimmune diseases, the burden of the symptoms, but also the burden of, uh, therapies they need to take chronically, uh, usually with those diseases.
And CAR T can provide this promise of freeing them from these, uh, from these burdens.
Uh, so as a company, we've been focused since the beginning to bring, uh, the potential of cell therapy, and specifically CAR Ts, uh, to patients who are suffering from autoimmune diseases.
So our first indications we're developing is stiff person syndrome, and I'm sure we're gonna talk about this, but also other debilitating diseases like myasthenia gravis and other, uh, neuroimmunological diseases that we're pursuing earlier in our pipeline.
So really the focus of, um, of our team has been to advance, uh, this, uh, this therapy, uh, that is still investigational, but really develop it and bring it to patients because it can have this promise of freeing patients from the burden of their autoimmune diseases, the burden of the symptoms, but also the burden of, uh, therapies they need to take chronically, uh, usually with those diseases.
And CAR T can provide this promise of freeing them from these, uh, from these burdens.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
